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ABSTRACT
A formulation containing 40% of honey, 30% of black cumin, 20% of propolis and 10% of royal
jelly has been available in the market for the treatment of diabetes. Although each content of
the formulation is proven to possess antioxidant and antihyperglycemic activities, its combination
effect has not been evaluated yet. The aim of this study was to evaluate the effect of this
formulation on blood glucose level and pancreatic-cells of streptozotocin (STZ)-induced diabetic
rats. Thirty six male Wistar rats (Rattus novergicus) aged 11 weeks with body weight 100-150 g
were used in this study. The rats were divided into 6 groups with 6 rats in each group. Group 1
was non diabetic rats that were given aquadest. Group 2 was diabetic rats that were given
aquadest. Group 3 was diabetic rats that were given metformin at dose of 45 mg/kg BW. Group
4-6 were diabetic rats that were given formulation tested at dose of 3, 6 and 12 mL/kg BW,
respectively. All rats were induced by intraperitoneal injection of STZ at 60 mg/kg BW and
diabetic rats were then orally administered the formulation tested or metformin twice daily for
14 days. Blood glucose level was monitored on day 10 and 17 after STZ induction. Rats were
sacrificed and pancreas samples were taken for histopathological examination. The results showed
that the blood glucose level decreased significantly after seven days of treatment with metformin
or fomulation tested and continued after 14 days of treatment. The blood glucose level of
diabetic rats after 14 days of treatment returned to the normal level. The vacuolization of the
pancreatic -cells of diabetic rats treated with metformin or with formulation tested were lower
than untreated diabetic rats but still higher than non diabetic rats. In conclusion, the formulation
tested has antihyperglicemic and protective effect on -cells damage in diabetic rats.
ABSTRAK
Sebuah formulasi yang mengandung 40% madu, 30% jinten hitam, 20% propolis dan 10% royal
jeli telah tersedia di pasaran untuk mengobati diabetes. Meskipun masing-masing kandungan
formulasinya telah dibuktikan mempunyai aktivitas antioksidan dan antihiperglikemi, tetapi efek
kombinasinya belum pernah dikaji. Penelitian ini bertujuan untuk mengkaji efek pemberian fromulasi
tersebut pada gula darah dan sel-pankreas tikus diabetes yang diinduksi streptozotosin (STZ).
Tiga puluh enam tikus jantan Wistar (Rattus novergicus) berumur 11 minggu dengan berat badan
100-150 g digunakan dalam penelitian ini. Tikus dibagi 6 kelompok dengan masing-masing
kelompok 6 ekor. Kelompok 1 adalah tikus normal yang diberi akuades. Kelompok 2 adalah tikus
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diabetes yang diberi akuades. Kelompok 3 adalah tikus diabetes yang diberi metformin dosis 45
mg/kg BB. Kelompok 4-6 adalah tikus diabetes yang diberi formulasi dosis 3, 6 dan 12 mL/kg BB.
Tikus diinduksi STZ intraperitonial dengan dosis 60 mg/kg BB. Tikus diabetes kemudian diberi
metformsin atau formulasi uji dua kali sehari selama 14 hari. Kadar gula darah dimonitor pada
hari ke 10 dan 17 setelah induksi STZ. Tikus dikorbankan dan diambil pankreasnya untuk
pemeriksaan histopatologi. Hasil penelitian menunjukkan kadar gula darah menurun secara
bermakna setelah tuju hari perlakuan dengan metformin atau formulasi uji. Setelah hari ke 14
perlakuan, kadar gula darah kembali dalam kondisi normal. Vakuolisasi sel-pankreas tikus diabetes
yang diberi metformin atau formulasi uji lebih rendah dari pada tikus diabetes yang tidak diobati
tetapi masih lebih tinggi dari tikus normal. Dapat disimpulkan, formulasi uji mempunyai efek
antihiperglikemia dan efek protektif terhadap kerusakan sel-pankreas tikus diabetes.
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INTRODUCTION
The prevalence of diabetes mellitus (DM)
is increasing due to population growth, aging,
urbanization, and increasing prevalence of
obesity and physical inactivity. World Health
Organization (WHO) estimated that the
prevalence of DM in the world in 2000 reached
171,228 million and it will be 366,212 million
in 2030. In Indonesia, it was estimated that the
number of people with DM in 2000 increased
from 8.4 million to 21.3 million in 2030.
Indonesia is the fourth country with highest
number of people with DM in the world for
2000 and 2030 after India, China danAmerica.1
Diabetes mellitus is characterized with
hyperglycemia that is associated with
pancreatic-cells damage occurring together
with insulin resistance. Normal pancreatic â-
cells can compensate for insulin resistance by
increasing insulin secretion. However,
insufficient compensation leads to the onset of
glucose intolerance.2 Hyperglycemia generates
from reactive oxygen species (ROS) leading to
the increased oxidative stress in variety of
tissues including pancreas. The absence of
endegenous antioxidant compensates the
increase of oxidative stress causing cellular
damage that is responsible for diabetes
complications.3
Some formulations with natural products
have been used traditionally to treat DM since
a long time ago. One of the formulations
containing 40% of honey, 30% of black cumin,
20% of propolis and 10% of royal jelly has
been available in the market for the treatment
of diabetes. Although each content of the
formulation is proven to possess antioxidant and
antihyperglycemic activities, however its
combination effect has not been evaluated, yet.
Honey in combination with glibenclamide and
metformin has an antioxidant protective effect
in pancreas of STZ-induced diabetic rats, while
black cumin (Nigella sativa) has a protective
effects on -cells damage in STZ-induced
diabetic rats.4,5 Moreover, propolis possesses
antihyperglycemic activity in STZ-induced
diabetic rats 6,7 while royal jelly possesses
antioxidant and antihypercholesterolemic
activities.8
It is apparent that the different natural
products would work by different mechanism
in the decrease of hyperglycemic in diabetic rats.
However, very few studies are conducted to
evaluate a combination activity of the different
natural products as antihyperglycemic in
diabetic rats. This study was conducted to
evaluate the effect of a formulation containing
honey, black cumin, propolis and royal jelly on
blood glucose level of STZ-induced diabetic
rats. Its protective effect of this formulation on
the pancreatic -cells damage was also
investigated.
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MATERIALS AND METHODS
Animals and materials
This study was started after obtaining an
approval from the the Medical and Health
Research Ethics Committee, Gadjah Mada
University, Yogyakarta. Thirty six male Wistar
rats (Rattus novergicus) aged 11 weeks with
body weight 100-150 g obtained from the
Integrated Research and Testing Laboratory,
Universitas Gadjah Mada, Yogyakarta were
used in this study. The rats were housed at room
temperature under 12 hour cycles of dark and
light and were allowed standard food and water
ad libitum. The rats were divided into 6 groups
with 6 rats in each group. Group 1 as normal
contol was non diabetic rats that were given
aquadest. Group 2 as negative control was
diabetic rats that were given aquadest. Group 3
as positive control was diabetic rats that were
given metformin at dose of 45 mg/kg BW. Group
4-6 as treatment groups were given formulation
tested at dose of 3, 6 and 12 mL/kg BW,
respectively.
The formulation tested was the mixture of
40% honey, 30% black cumin, 20% propolis,
and 10% royal jelly obtained from CV Cahya
Sejati, Madiun. Streptozotocine was obtained
from Sigma Biomedical Inc. USA, and metfor-
min was obtained from Hexpharm Jaya,
Indonesia.
Induction of hyperglycemic and formulation
administration
Rats were used for the study after an
acclimatization period of one week and were
fasted for 18 hours before experimental sessions
but allowed to have a free access to water during
the experiment. Before STZ injection, blood
sample was taken from orbital sinus and blood
glucose level was determined by using GOD
PAP method. Hyperglycemia was induced by
intraperitoneal injection of STZ at 60 mg/kg BW,
freshly dissolved in citrate buffer (0.01 M and
pH 4.5). The day of STZ injection was
designated as day 0. Development of diabetes
was confirmed by measuring blood glucose
level three days after STZ injection (day 3).
Rats with blood glucose level higher than 200
mg/dL were considered to be diabetic9 and
selected for the experiment. The diabetic rats
were then orally administered the formulation
tested or metformin twice daily for 14 days.
Blood glucose level was monitored on day 10
and 17 after STZ injection.
Histopathological examination of
pancreatic-cells
At the end of experiment, rats were
sacrificed and a midline abdominal incision was
made. Pancreases were removed from the mice
and fixed in a solution of 10% buffered para-
formaldehyde, dehydrated in a graded ethanol
series, cleared in xylene and then embedded in
paraffin wax. Approximately 5-m sections
were prepared and stained with Gomori’s
chrome alum stain for detection of pancreatic
-cells.10 Olympus light microscopy was used
to examine the pancreatic-cells. Slides were
photographed using Olympus digital camera. The
pancreatic-cells were counted in chome alum
slides under 400 high power fields. In this study,
the number of pancratic -cells was assessed
by counting the number of vacuolated cytoplasm
of the blue stained cells inside one islet in the
field.Aminimum of 5 randomly selected fields
per section from each rat were analiysed.
Statistical analysis
All results were expressed as mean ±
standar deviation (SD). Blood glucose were
compared by a one or two-way ANOVA. A
p<0.05 was considered to be statistically
significant.
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RESULTS
Blood glucose level of non diabetic, diabe-
tic, metformin treated diabetic, formulation
treated diabetic rats groups on day 0, 3, 10 and
17 after STZ injection are shown in TABLE 1
and FIGURE 1. The blood glucose level of all
groups before STZ injection (day 0) were in
normal level. Three days after STZ injection
(day 3), rats were diabetic as demonstrated with
a blood glucose level higher than 200 mg/dL.
Seven days (day 10) after treatment with metfor-
min or formulation tested, blood glucose level
was significantly reduced compared with before
treatment (day 0) (p<0.05) and was in a normal
state (<200 mg/mL). Moreover, blood glucose
level of rats after treatment with metformin or
formulation tested were significantly lower than
blood glucose level of untreated diabetic rats
(p<0.05). The decrease of blood glucose level
of rats continued on day 17 after treatment with
metformin and formulation tested, whereas the
blood glucose level of untreated diabetic rats
were similar on day 3, 10 and 17 after STZ
injection.
TABLE 1. Blood glucose level of non diabetic, diabetic, metformin treated diabetic, formulation treated diabetic
rats groups on day 0, 3, 10 and 17 after STZ injection
FIGURE 1. Blood glucose level of each rat group on day 0, 3, 10 and 17 after STZ
injection. Group 1: non diabetic rats; Group 2: diabetic rats; Group 3:
diabetic rats + metformin 45 mg/kg BW; Group 4: diabetic rats +
formulation 3 mL/kg BW; Group 5: diabetic rats + formulation 6 mL/kg
BW; Group 6: diabetic rats + formulation 12 mL/kg BW.
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Pancreatic-cells of a normal rat, diabetic rat and diabetic rat after treatment with metformin
and formulation after Gomori’s chrome alum staining are presented in FIGURE 2.
FIGURE 1. Pancreatic -cells of 1) non diabetic rat, 2) untreatet diabetic rat, 3)
metformin treated diabetic rat at 9 mg/kg BW, 4) formulation treated
diabetic rat at 12 mL/kg BW, 5) formulation treated diabetic rat at 6 mL/
kg BW, 6) formulation treated diabetic rat at 3 mL/kg BW
The average cytoplasmic vacuolization of
the pancreatic -cells of non diabetic rats,
untreated diabetic rats and rats after 14 days
administration with metformin and formulation
tested are shown in TABLE 2. The biggest
number of cytoplasmic vacualization of
pancreatic-cells was observed on untreated
diabetic rats, while the lowest cytoplasmic
vacuolization was observed on non diabetic rats
(p<0.05). The cytoplasmic vacuolization of the
pancreatic-cells on diabetic rats treated with
metformin or with formulation tested were
lower than untreated diabetic rats but still higher
than non diabetic rats (p<0.05). The lowest
vacuolization of pancreatic-cells of diabetic
rats after administration of formulation tested
was observed at dose 3 mL/kg BW.
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TABLE 2. The cytoplasmic vacuolization of the
pancreatic -cells of non diabetic rats,
untreated diabetic rats and rats after 14
days administration with metformin and
formulation tested
DISCUSSION
Before STZ induction, the blood glucose
level of rats used in this study was still in a
normal value range. As reported by Butler11,
the normal blood glucose level of healthy rats
varies between 50 to 135 mg/dL depending on
the type of food consumed and time since the
last meal. Three days after STZ induction, the
blood glucose level increased significantly
from 231 to 238 mg/dL (TABLE 1) indicating
that the rats were diabetic.9
Streptozotocin is an antibiotic isolated from
Streptomyces achromenes that is commonly
used to induce diabetic in experimental model
animal. Streptozotocin possesses â-cell
cytotoxic effect that is associated with the
inhibition of free radical scavenger enzymes,
thereby enhancing the production of superoxide
radical. The diabetic animal caused by STZ is
associated with the generation of ROS causing
oxidative damage of-cell.12,13
This study was conducted to evaluate effects
of a formulation containing containing honey,
black cumin, propolis and royal jelly on blood
glucose level and pancreatic-cells damage in
STZ-induced diabetic rats. The results showed
that the blood glucose level of all STZ-induced
diabetic rats decreased significantly after seven
days of treatment with fomulation tested (day
10) and continued decreasing after 14 days of
treatment (day 17) to the normal level (<200
mg/dL). Therefore, it was indicated that the
formulation has antihypergliceminc effect.
The antihyperglicemic effect of the
formulation might be resulted from the
combination of each effect of all the contents in
the formulation. The activity of the content of
the formulation as antioxidant and antihyper-
glicemic has been evaluated by some authors.
Honey is reported to be able to significantly
reduce blood glucose level in alloxan-iduced
and STZ-induced diabetic rats.4,14,15 The
possible mechanism of action of honey as
antihyperglycemic is reviewed by Erejuwa et
al.16 The potential mechanism of actions of
honey may be based on its non antioxidant and
antioxidant effect of constituents. Honey
increases plasma fructose level that leads to
increased hepatic glucose uptake by activating
glucokinase. Moreover, some of minerals in
honey such as chromiun are recognized for their
role in the reduction of elevated blood glucose,
and maintenance of normal glucose tolerance
and insulin secretion from the pancreatic â-cells.
A number of studies have shown that honey can
scavenge free radicals, ameliorate oxidative
stress in the pancreas, protect the pancreas
against oxidative damage and thus enhance
insulin secretion resulting in improved glycemic
control.
The effect of antihyperglicemic in black
cumin (Nigella sativa) in diabetic animal
models has been reported.5,17 The antihyper-
glicemic effect of N. sativa is mediated through
activation of theAMPK pathway that increased
muscle Glut4 content.18 Nigella sativa also
reported to be able to decrease oxidative stress,
preserve the integrity and protect the damage
of pancreatic -cell that is caused by hyper-
glicemic in diabetic rats.19,20 In addition, N.
sativa is reported to inhibit intestinal glucose
absorption and improves glucose tolerance in
rats.21
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The effect of propolis as antihyperglycemic
in STZ-induced diabetic rats has been also
reported.6,7,22 The antihyperglycemic effect of
propolis is mediated through reduction of
expression of glucose-6-phosphatase through
inhibition of Y279 and Y216 autophosphorylat-
ion of GSK-3/in HepG2 cells.23 Propolis is
also reported to possess-cell protective effect
against the toxicity of STZ in rats. The free
radical scavenging effect together with IL-1
and nitric oxide (NO) synthase inhibitory effect
are thought to be the main factors for the
protective effect of propolis against STZ
toxicity.24
Royal jelly has been proven to possess
antioxidant and antihypercholesterolemic
activities.8 Royal jelly peptides are isolated
from hydrolysates of water-soluble royal jelly
proteins peptides to inhibit lipid peroxidation
both in vitroand in vivo.25 Antioxidant effect of
royal jelly is used against oxidative stress of
the kidney and liver injury caused by cytotoxic
agents.26,27
In this study, most of the pancreatic â-cells
of non diabetic rats were stained deep blue in
the cytoplasma as previously reported by Rifaai
et al.28 On untreated diabetic rats, degenerative
changes of the pancreatic-cells were observed
as indicated by a significant decrease in the
density of bluish stained and the increase in
cytoplasmic vacuolization of-cells (p<0.05).29
Treatment with metformin or formulation tested
was able to significantly decrease the cyto-
plasmic vacuolization of -cells (p<0.05)
although it was still higher than on non diabetic
rats. It was thought that the formulation has
antihyperglicemic effect through its protective
effect of-cells damage.
CONCLUSION
In conclusion, the formulation tested
containing 40% of honey, 30% of black cumin,
20% of propolis and 10% of royal jelly has
antihyperglicemic effect in STZ-induced
diabetic rats. Moreover, the fromulation also
has a protective effect on-cells damage in the
diabetic rats. In addition, further study in order
to evaluate the toxicity of the formulation should
be conducted.
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